Search clinical trials for: Ig G4

Total 8873 results

DexCom, Inc.

Completed

Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System

Diabetes

United States
Gilead Sciences
California Institute for Regenerative Medicine (CIRM)

Completed

CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United Kingdom
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease (RetroG4)

IgG4-related Disease | Orbital Infections, Inflammations and Irritations

France
Peking Union Medical College Hospital

Recruiting

Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement

Autoimmune Diseases

China
Meir Medical Center

Unknown

A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood

IgG4-related Disease | Aortic Aneurysm

Israel
Vastra Gotaland Region
DexCom, Inc.

Completed

CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections

Diabetes Mellitus, Type 1

Sweden
Wen Zhang
Beijing Friendship Hospital; Tongji Hospital

Recruiting

Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD

IgG4-related Disease With Eosinophilia

China
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems (SPACE2)

Diabetes Mellitus

Netherlands
Shantha Biotechnics Limited

Completed

A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers

Rotavirus Gastroenteritis

India
Peking Union Medical College Hospital

Unknown

Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4-RD

Plasmablast/Plasma Cells in Diagnosis of IgG4-RD | Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD

China
Peking Union Medical College Hospital

Unknown

Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids

Obstructive Jaundice | Autoimmune Pancreatitis | IgG4-related Sclerosing Cholangitis

China
Vastra Gotaland Region

Completed

Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes

Diabetes Mellitus, Type 1 | Blood Glucose

Sweden
Hoffmann-La Roche

Terminated

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
HealthPartners Institute
The Leona M. and Harry B. Helmsley Charitable Trust

Completed

Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)

Type 1 Diabetes

United States
Serum Institute of India Pvt. Ltd.
PATH

Completed

A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants

Rotavirus Gastroenteritis

India
Incyte Corporation

Active, not recruiting

A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

Metastatic Merkel Cell Carcinoma

United Kingdom, United States, Germany, Canada, Czechia, Italy, France, Spain, Switzerland, Australia, Poland, Hungary
Fondazione GISE Onlus
University of Padova; Abbott

Recruiting

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the MitraClip G4

Mitral Valve Regurgitation

Italy
Boston Children's Hospital

Completed

Adjusting Insulin Delivery to Activity (AIDA)

Diabetes | Nocturnal Hypoglycemia

United States
University Hospital, Lille

Completed

TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure (READIAB-G4)

Hyperglycemia | Genetic Predisposition to Disease | Multiple Organ Failure | Intensive Care Unit Syndrome

France
Universidad Politecnica de Madrid

Recruiting

Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms

Immunoglobulin G4-Related Disease | Symptoms and Signs | Immunoglobulin E-Mediated Food Allergy | Adverse Reaction to Food

Spain
Chinese University of Hong Kong

Completed

Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients (IgG4-COVID)

Covid19 | IgG4 Related Disease

Hong Kong
Gilead Sciences
Merck KGaA, Darmstadt, Germany

Completed

Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy

Ovarian Cancer

United States
Shantha Biotechnics Limited

Unknown

Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine

Rotavirus Gastroenteritis

India
DexCom, Inc.

Completed

Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System (GLYCOAIM)

Diabetes Mellitus

United States
Stanford University
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

Lymphoma

United States
Gilead Sciences
California Institute for Regenerative Medicine (CIRM)

Completed

Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer

Colorectal Cancer | Solid Tumor

United States
Centre Hospitalier du Luxembourg
University of Cambridge

Completed

Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg

Type 1 Diabetes Mellitus

Luxembourg
University of Virginia
Stanford University

Completed

Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study

Diabetes Mellitus, Type 1

United States
DexCom, Inc.

Completed

Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes Mellitus

Pediatric Subjects With Diabetes Mellitus

United States
Mayo Clinic
Celgene Corporation

Completed

Treatment of IgG4-Related Disease With Revlimid and Rituximab (TIGR2)

IgG4-related Disease | Retroperitoneal Fibrosis | Autoimmune Pancreatitis | IgG4-related Sclerosing Cholangitis | Immunoglobulin G Subclass 4 Related Disease

United States
McGill University Health Centre/Research Institute...
Institut de Recherches Cliniques de Montreal

Unknown

Insulin-based Strategies to Prevent Hypoglycemia During Exercise

Type 1 Diabetes Mellitus

Canada
Assiut University

Unknown

Evaluation Of Pleural Effusion At Assiut University Hospital

Pleural Effusion
Hoffmann-La Roche

Completed

Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Injection in Healthy Participants

Healthy Participants

United States
DexCom, Inc.

Completed

Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in Pediatrics

Diabetes Mellitus

United States
DexCom, Inc.

Completed

Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System

Diabetes

United States
Shantha Biotechnics Limited
PATH

Withdrawn

Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants

Rotavirus Infections

India
Gilead Sciences

Terminated

Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) (ENHANCE)

Myelodysplastic Syndromes

United States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
Stanford University
Merck Sharp & Dohme LLC

Suspended

Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Relapsed Classical Hodgkin Lymphoma

United States
Meir Medical Center

Recruiting

Meir Medical Center Rheumatologic Biobank

Rheumatoid Arthritis | Lupus Erythematosus, Systemic | Systemic Sclerosis | IgG4-related Disease | Sjogren's Syndrome

Israel
Universidade Federal do Amazonas

Completed

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer (PRONIC-G)

Gastric Cancer | Nutritional Status | Gastric Adenocarcinoma | Cytokines | Microbiome

Brazil
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Gilead Sciences
The Leukemia and Lymphoma Society

Terminated

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Non Hodgkin Lymphoma

United States, Australia, United Kingdom
DexCom, Inc.

Completed

Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus

Diabetes Mellitus

United States
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; University of Bern

Recruiting

Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma (MACOCUC-01)

Advanced Urothelial Carcinoma

Switzerland
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)

Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9

China
Gilead Sciences

Terminated

Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies

Hematological Malignancies

United States, United Kingdom
Radboud University Medical Center
Dutch Kidney Foundation

Completed

Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy (ACTHiMeN)

Idiopathic Membranous Nephropathy

Netherlands
NYU Langone Health
Bristol-Myers Squibb; Daiichi Sankyo, Inc.

Completed

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Melanoma

United States
Astex Pharmaceuticals, Inc.

Terminated

A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

United States
PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Recruiting

Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Systemic Lupus Erythematosus | Systemic Sclerosis | Idiopathic Inflammatory Myopathies | Primary Sjögren Syndrome | IgG4 Related Disease

China

Search clinical trials for: Ig G4

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations